Bazsa you haven't even highlighted a statement properly. You've cut out the edge of the text that you are asking someone to explain to you.
You write - Has the trial been unblinded? No DSMB review and they call it a succesfull clinical activitie.
You are miss spelling a lot of basic words.
I think you mean this one -
"Giventhe success of ongoing clinical activities including the Phase 3 SCUlpTOR trial, Phase 1 DFU trial, and proposedPhase 2 aGvHD trial, the Company prioritised resources towards these initiatives and concluded the MENDrespiratory distress clinical trial."
Taken on its face and assuming that that is the statement you are asking about. I think there has been some very modest success in the Phase 3 SCulpTOR trial. So its not wrong to say "given some". Ditto some "success" in DFU, very modest.
Is it a pump ? - well its positive spin that I grant you that - most company ASX announcements spin positively what they can. I don't recall many being pleased and proud as CYP was in the annual report over what seemed to be so little achieved in 12 months.
Would I prefer they were reporting more concrete metrics of success to prove they'd achieved more concrete metrics of success - of course I would so I think would all shareholders prefer that.
CYP Price at posting:
31.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)